News and Announcements
Rapid Response Revival appoints Mr Robert Karp as a Non-Executive Director to the Company Board
- Published February 11, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Mr Robert (Robi) Karp is the CEO and owner of Fluffy Spider Technologies and is a Member of the Advisory Board to the Faculty of Software Engineering and Computer Science, University of Wollongong. Robi holds a BSc. Computer Science, Mathematics (UNSW).
Robi has had a distinguished career of over 30 years in software development, methods and ecosystems used in consumer electronics, semiconductors, Internet Services in positions such as Chief Technology Officer and Chief Executive Officer. Robi has over 20 years experience in the development and commercialisation of software solutions with Original Equipment Manufacturers worldwide.
Robi is the co-inventor of patented “System and Methods for a runtime configurable user interface controller “, for use with consumer electronics devices. US Patent 10,248,438 Nash et al.
Having worked closely with MedTech and Medical Devices companies he will be able to act as a valuable sounding board for the technical leadership team of RRR and, through his extensive professional network around the world, provide opportunities for relevant business and technical opportunities, as well as working with the Board to formulate strategies around IP identification and protection, to ensure the value created at RRR is captured for the benefit of RRR and its shareholders.
About Rapid Response Revival Research Limited
Rapid Response Revival are the innovators behind the CellAED® defibrillator technology – transforming everyday people into heroes.
Sudden Cardiac Arrest (SCA) has an extremely high death rate and is a leading cause of death globally, accounting for more deaths than many cancers, influenza, car accidents and house fire deaths combined. Anyone can suffer from SCA, regardless of age, gender or fitness level – including children. The current survival rate is just 2-11%.
The CellAED® is designed to assist everyday people and medical professionals to prevent many unnecessary deaths. It is a lightweight, affordable, and personal Automated External Defibrillator (AED) solution, targeting the current government and enterprise market as well as the personal and home AED market.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
